Combined treatment of bronchial epithelial calu-3 cells with peptide nucleic acids targeting mir-145-5p and mir-101-3p: synergistic enhancement of the expression of the cystic fibrosis transmembrane conductance regulator (cftr) gene

HIGHLIGHTS

• who: Chiara Papi and collaborators from the Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy have published the research: Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene, in the Journal: (JOURNAL)
• what: The aim of this study was to verify whether combined treatments with the most active PNAs are associated with increased expression. Figure 1B shows aCalu-3 computer-aided analysis demonstrating thatShort miR-145-5p . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.